JiangXi Tianxin Pharmaceutical Co., Ltd.SSE: 603235

(603235)"JIANGXI TIANXIN PHARMACEUTICAL CO., LTD."Announcement on Operating Data for Q3 2026

· Issued by JiangXi Tianxin Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Stock code 603235 · · 2 pages · Chinese

Summary by 6ix AI

The report includes revenue figures categorized by product, channel, and region, showing a mix of increases and decreases compared to the previous year. The company emphasizes that the data is unaudited and advises investors to be cautious in their decision-making.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

JiangXi Tianxin Pharmaceutical Co., Ltd. on 6ix

Story so far

Earlier from JiangXi Tianxin Pharmaceutical

Later from JiangXi Tianxin Pharmaceutical

All JiangXi Tianxin Pharmaceutical news releases